Research Report of China Pharmaceutical Industry in 2009

February 2010 | 20 pages | ID: R357153484CEN
SunFaith China Ltd.

Abstracts

For China pharmaceutical industry, 2009 was a year when a series of policies were launched concerning price fluctuation, items covered in national basic medical insurance as well as drug distribution, backing up the implementation of the new health care reform. With the promotion and implementation of the new medical reform policy, the demand of China pharmaceutical industry will be further unleashed, ensuring the stability of sales volume of this field. From Jan to Nov 2009, China medicine manufacturing industry posted a sales revenue of RMB 796.37 billion. This report makes analysis of the production, trading and marketing of China pharmaceutical industry and makes prediction of the future development of the industry.

Contents

1. PRODUCTION OF MAIN PRODUCTS

1.1 Chemical Raw Materials
  1.1.1 Cumulative production
  1.1.2 Monthly production
  1.1.3 Production of chemical raw materials in key cities and regions
1.2 Traditional Chinese Medicine
  1.2.1 Cumulative production
  1.2.2 Monthly production
  1.2.3 Production of traditional Chinese medicine in key cities and regions

2. IMPORT & EXPORT OF MAIN PRODUCTS

1.3 Pharmaceuticals
1.4 Antibiotics
1.5 Antibiotic agent
1.6 Traditional Chinese medicine

3. SALES STATUS ANALYSIS

4. PRICE FLUCTUATION ANALYSIS

5. FINANCIAL SITUATION OF PHARMACEUTICAL INDUSTRY (IN DIFFERENT CORPORATE SIZES AND OF DIFFERENT ECONOMIC TYPES)

1.7 Industry Capacity for Growth
1.8 Cost structure
1.9 Repayment capability
1.10 Operation capacity

6. PROSPECT ANALYSIS OF PHARMACEUTICAL INDUSTRY